Protalix BioTherapeutics
PLX
#8915
Rank
โ‚น12.49 B
Marketcap
โ‚น155.42
Share price
-1.14%
Change (1 day)
8.62%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -โ‚น3.42

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น3.59. In 2024 the company made an earnings per share (EPS) of โ‚น3.59 a decrease over its 2023 EPS that were of โ‚น10.78.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น3.42-195.21%
2024โ‚น3.59-66.67%
2023โ‚น10.78-138.71%
2022-โ‚น27.85-50%
2021-โ‚น55.70181.82%
2020-โ‚น19.76-82.11%
2019-โ‚น110.50-31.67%
2018-โ‚น161.71-72.31%
2017-โ‚น583.94124.14%
2016-โ‚น260.53-147.54%
2015โ‚น548.00-290.63%
2014-โ‚น287.486.67%
2013-โ‚น269.51130.77%
2012-โ‚น116.79-69.77%
2011-โ‚น386.3019.44%
2010-โ‚น323.41-12.2%
2009-โ‚น368.3336.67%
2008-โ‚น269.51-37.5%
2007-โ‚น431.2150%
2006-โ‚น287.483.23%
2005-โ‚น278.49138.46%
2004-โ‚น116.79-74%
2003-โ‚น449.18-0%
2002-โ‚น449.18-50%
2001-โ‚น898.36233.33%
2000-โ‚น269.51-84.21%
1999-โ‚น1,707-24%
1998-โ‚น2,246-600%
1997โ‚น449.18-16.67%
1996โ‚น539.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-โ‚น9.88 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น387.19-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.52-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.60-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel